Clinical Trials Directory

Trials / Completed

CompletedNCT03195504

High-flow Nasal Oxygenation in Obese Patients During Apnea

Effectiveness of Apneic Oxygenation Using High-flow Nasal Cannula in Morbidly Obese Patients Undergoing General Anesthesia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Before going off to sleep patients are given oxygen to saturate blood with oxygen to extend time before a decrease in the level of oxygen in the blood occurs. During this period, obese patients have a faster decrease in the level of oxygen in their blood. This study uses a device called "high-flow nasal cannula" (HFNC), which delivers humidified high-flow oxygen through 2 small plastic tubes placed just inside nostrils. In the intensive care unit settings this device has been used extensively and has become a standard practice. Purpose of this study is to determine whether these high-flow nasal cannula increase the time safely when going to sleep during elective surgery.

Conditions

Interventions

TypeNameDescription
DEVICEHFNCHigh flow nasal oxygen (60 l) under GA
DEVICECON (control)Standard oxygen (10-15 l) under GA

Timeline

Start date
2017-08-10
Primary completion
2018-04-01
Completion
2018-04-01
First posted
2017-06-22
Last updated
2019-04-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03195504. Inclusion in this directory is not an endorsement.